UnitedHealthcare and Humana Discontinue Medicare Advantage Plans Affecting 1M Beneficiaries
UnitedHealthcare and Humana are discontinuing several Medicare Advantage plans, affecting nearly 1 million beneficiaries, as part of broader strategies to streamline operations and improve profitability.
The decisions underscore a significant shift in the insurance industry, where major providers like UnitedHealthcare and Humana are responding to unexpected healthcare utilization spikes and rising medical costs. For UnitedHealthcare, this means eliminating certain Preferred Provider Organization (PPO) plans impacting 390,000 members, particularly in less profitable regions. This strategy, informed by financial projections for 2025, reflects the insurer's need to adapt to evolving market pressures. Meanwhile, Humana plans to end coverage for approximately 600,000 members by 2027. With about 8% of its 7.2 million Medicare members affected, the company aims to reallocate resources to more financially viable programs, as highlighted by Chief Financial Officer Celeste Mellet.
These changes have broader implications for the Medicare Advantage marketplace. Increasing out-of-pocket expenses, shrinking provider networks, and fewer supplemental benefits are becoming common industry responses to rising healthcare costs. According to Alexis Levy from HealthScape Advisors, while policyholders may retain their providers, the coverage level could diminish compared to previous years. Additionally, the market is experiencing a decline in $0 premium prescription drug plans, once a popular offering. UnitedHealthcare is focusing on plans with limited provider networks and expanding offerings for chronic condition management—key growth drivers in the Medicare Advantage segment, as noted by industry experts.
- UnitedHealthcare: Terminating specific PPO plans affecting 390,000 members by 2025
- Humana: Ending coverage for approximately 600,000 members by 2027
- Market impact: Increased out-of-pocket costs and reduced provider networks
- Trend: Decline in $0 premium prescription drug plans
- Focus: UnitedHealthcare expands chronic condition management offerings